CANCERINFORMER
BREAKING

Therapeutic Areas

Or, sign up for our newsletter


Advertisement

Therapeutic Areas

ESMO-releases-the-first-guideline-on-NGS-testing- in-cancers

ESMO releases the first guideline on NGS testing in cancers

Precision therapies were first approved for cancer in 1998, when trastuzumab was approved for HER2+ breast cancer, opening the door for other targeted therapies such as imatinib for Philadelphia chromosome-positive chronic myelogenous leukaemia.

Copy link
Powered by Social Snap
MediPaper Medical Communications Agency Hong Kong Blog